Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis
- 1 December 1991
- journal article
- clinical trial
- Published by Elsevier in Bone and Mineral
- Vol. 15 (3) , 237-247
- https://doi.org/10.1016/0169-6009(91)90129-n
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Treatment of paget's disease of bone with aminohydroxybutylidene bisphosphonateJournal of Bone and Mineral Research, 1990
- Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.Journal of Clinical Investigation, 1990
- Treatment of painful bone lesions and hypercalcemiaEuropean Journal of Haematology, 1989
- Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.Journal of Clinical Investigation, 1989
- Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronateJournal of Bone and Mineral Research, 1989
- Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1–38)hPTH and diphosphonate EHDPJournal of Molecular Medicine, 1988
- Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: The effect of a bisphosphonateJournal of Bone and Mineral Research, 1988
- Does Calcium Supplementation Prevent Postmenopausal Bone Loss?New England Journal of Medicine, 1987
- MEASUREMENT OF PAINPublished by Elsevier ,1974